...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Not good for the potential of apabetalone as a Covid-19 therapy

"I return to my earlier disgust over trial design - when it became clear that they had not designed the study to even evaluate  benefits against long covid, where apabetalone seemed most likely to shine." (imtesty)

 

I agree wholeheartedly with that statement..bang on...Long Covid

Share
New Message
Please login to post a reply